{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T14:47:38Z","timestamp":1785163658806,"version":"3.55.0"},"reference-count":56,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2021,11,22]],"date-time":"2021-11-22T00:00:00Z","timestamp":1637539200000},"content-version":"vor","delay-in-days":325,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["GRK2099"],"award-info":[{"award-number":["GRK2099"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005972","name":"Deutsche Krebshilfe","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005972","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010124","name":"Erich und Gertrud Roggenbuck-Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010124","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>The prognosis of patients with brain metastases (BM) is poor despite advances in our understanding of the underlying pathophysiology. The high incidence of thrombotic complications defines tumor progression and the high mortality rate. We, therefore, postulated that von Willebrand factor (VWF) promotes BM via its ability to induce platelet aggregation and thrombosis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We measured the abundance of VWF in the blood and intravascular platelet aggregates of patients with BM, and determined the specific contribution of endothelial and platelet-derived VWF using in vitro models and microfluidics. The relevance for the brain metastatic cascade in vivo was demonstrated in ret transgenic mice, which spontaneously develop BM, and by the intracardiac injection of melanoma cells.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Higher levels of plasma VWF in patients with BM were associated with enhanced intraluminal VWF fiber formation and platelet aggregation in the metastatic tissue and peritumoral regions. Platelet activation triggered the formation of VWF multimers, promoting platelet aggregation and activation, in turn enhancing tumor invasiveness. The absence of VWF in platelets, or the blocking of platelet activation, abolished platelet aggregation, and reduced tumor cell transmigration. Anticoagulation and platelet inhibition consistently reduced the number of BM in preclinical animal models.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Our data indicate that platelet-derived VWF is involved in cerebral clot formation and in metastatic growth of melanoma in the brain. Targeting platelet activation with low-molecular-weight heparins represents a promising therapeutic approach to prevent melanoma BM.<\/jats:p><\/jats:sec>","DOI":"10.1093\/noajnl\/vdab175","type":"journal-article","created":{"date-parts":[[2021,12,30]],"date-time":"2021-12-30T16:48:04Z","timestamp":1640882884000},"source":"Crossref","is-referenced-by-count":4,"title":["Involvement of platelet-derived VWF in metastatic growth of melanoma in the brain"],"prefix":"10.1093","volume":"3","author":[{"given":"Jose R","family":"Robador","sequence":"first","affiliation":[{"name":"Department of Dermatology and Venereology, University Hospital Hamburg-Eppendorf , Hamburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6459-1899","authenticated-orcid":false,"given":"Manuel J","family":"Feinauer","sequence":"additional","affiliation":[{"name":"Neurology Clinic and National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany"},{"name":"Clinical Cooperation Unit Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan W","family":"Schneider","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Venereology, University Hospital Hamburg-Eppendorf , Hamburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank T","family":"Mayer","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Venereology, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Gorzelanny","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Venereology, University Hospital Hamburg-Eppendorf , Hamburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Artur","family":"Sacharow","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Venereology, University Hospital Hamburg-Eppendorf , Hamburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobo","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Venereology, University Hospital Hamburg-Eppendorf , Hamburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Berghoff","sequence":"additional","affiliation":[{"name":"Neurology Clinic and National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany"},{"name":"Clinical Cooperation Unit Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria A","family":"Brehm","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Venereology, University Hospital Hamburg-Eppendorf , Hamburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Hirsch","sequence":"additional","affiliation":[{"name":"Institute of Pathology, University Medical Center Mannheim, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Stadler","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Venereology, University Hospital Hamburg-Eppendorf , Hamburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Vidal-y-Si","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Venereology, University Hospital Hamburg-Eppendorf , Hamburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Wladykowski","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Venereology, University Hospital Hamburg-Eppendorf , Hamburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisse","family":"Asong","sequence":"additional","affiliation":[{"name":"Division of Translational Cancer Research, Department of Laboratory Medicine, Lund University, Lund, Sweden"},{"name":"Lund Stem Cell Center, Department of Laboratory Medicine, Lund University, Lund, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Nowak","sequence":"additional","affiliation":[{"name":"Department of Surgery, RoMed Kliniken Klinkum Rosenheim, Rosenheim, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"Seiz-Rosenhagen","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Municipal Hospital Memmingen, Memmingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktor","family":"Umansky","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Venereology, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany"},{"name":"Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Mess","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Venereology, University Hospital Hamburg-Eppendorf , Hamburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Pantel","sequence":"additional","affiliation":[{"name":"Department of Tumor Biology, University Medical Centre Hamburg-Eppendorf , Hamburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Winkler","sequence":"additional","affiliation":[{"name":"Neurology Clinic and National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany"},{"name":"Clinical Cooperation Unit Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander T","family":"Bauer","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Venereology, University Hospital Hamburg-Eppendorf , Hamburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,11,22]]},"reference":[{"issue":"12","key":"2021123016465484100_CIT0001","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1093\/neuonc\/not112","article-title":"Invasion patterns in brain metastases of solid cancers","volume":"15","author":"Berghoff","year":"2013","journal-title":"Neuro Oncol."},{"issue":"1","key":"2021123016465484100_CIT0002","doi-asserted-by":"crossref","first-page":"i1","DOI":"10.1093\/neuonc\/now197","article-title":"Systemic therapy of brain metastases: non-small cell lung cancer, breast cancer, and melanoma","volume":"19","author":"Chamberlain","year":"2017","journal-title":"Neuro Oncol."},{"issue":"3","key":"2021123016465484100_CIT0003","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.trecan.2018.01.003","article-title":"The evolving landscape of brain metastasis","volume":"4","author":"Valiente","year":"2018","journal-title":"Trends Cancer."},{"issue":"4","key":"2021123016465484100_CIT0004","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/CMR.0b013e328353efd8","article-title":"Risk of intracranial hemorrhage with anticoagulation therapy in melanoma patients with brain metastases","volume":"22","author":"Alvarado","year":"2012","journal-title":"Melanoma Res."},{"issue":"7","key":"2021123016465484100_CIT0005","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1161\/STROKEAHA.118.021373","article-title":"Risk of ischemic and hemorrhagic strokes in occult and manifest cancers","volume":"49","author":"Andersen","year":"2018","journal-title":"Stroke."},{"issue":"19","key":"2021123016465484100_CIT0006","doi-asserted-by":"crossref","first-page":"7899","DOI":"10.1073\/pnas.0608422104","article-title":"Shear-induced unfolding triggers adhesion of von Willebrand factor fibers","volume":"104","author":"Schneider","year":"2007","journal-title":"Proc Natl Acad Sci USA."},{"issue":"3","key":"2021123016465484100_CIT0007","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/rth2.12197","article-title":"The role of ADAMTS-13 and von Willebrand factor in cancer patients: results from the Vienna Cancer and Thrombosis Study","volume":"3","author":"Obermeier","year":"2019","journal-title":"Res Pract Thromb Haemost."},{"issue":"4","key":"2021123016465484100_CIT0008","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1160\/TH13-09-0800","article-title":"The various states of von Willebrand factor and their function in physiology and pathophysiology","volume":"111","author":"Huck","year":"2014","journal-title":"Thromb Haemost."},{"issue":"20","key":"2021123016465484100_CIT0009","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1182\/blood-2014-08-595686","article-title":"von Willebrand factor fibers promote cancer-associated platelet aggregation in malignant melanoma of mice and humans","volume":"125","author":"Bauer","year":"2015","journal-title":"Blood."},{"issue":"42","key":"2021123016465484100_CIT0010","doi-asserted-by":"crossref","first-page":"68527","DOI":"10.18632\/oncotarget.11832","article-title":"Heparins that block VEGF-A-mediated von Willebrand factor fiber generation are potent inhibitors of hematogenous but not lymphatic metastasis","volume":"7","author":"Goertz","year":"2016","journal-title":"Oncotarget."},{"issue":"9","key":"2021123016465484100_CIT0011","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1182\/blood.2020005710","article-title":"Local blood coagulation drives cancer cell arrest and brain metastasis in a mouse model","volume":"137","author":"Feinauer","year":"2021","journal-title":"Blood."},{"issue":"13","key":"2021123016465484100_CIT0012","doi-asserted-by":"crossref","first-page":"4382","DOI":"10.1158\/1078-0432.CCR-09-0399","article-title":"Activation of p38 mitogen-activated protein kinase drives dendritic cells to become tolerogenic in ret transgenic mice spontaneously developing melanoma","volume":"15","author":"Zhao","year":"2009","journal-title":"Clin Cancer Res."},{"issue":"1","key":"2021123016465484100_CIT0013","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nm.2072","article-title":"Real-time imaging reveals the single steps of brain metastasis formation","volume":"16","author":"Kienast","year":"2010","journal-title":"Nat Med."},{"issue":"7","key":"2021123016465484100_CIT0014","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1161\/ATVBAHA.113.303016","article-title":"von Willebrand factor directly interacts with DNA from neutrophil extracellular traps","volume":"34","author":"Gr\u00e4ssle","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol."},{"issue":"8","key":"2021123016465484100_CIT0015","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1182\/blood.V92.8.2791","article-title":"Tissue distribution and regulation of murine von Willebrand factor gene expression in vivo","volume":"92","author":"Yamamoto","year":"1998","journal-title":"Blood."},{"issue":"5","key":"2021123016465484100_CIT0016","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1182\/blood-2015-02-629717","article-title":"Platelet glycoprotein VI binds to polymerized fibrin and promotes thrombin generation","volume":"126","author":"Mammadova-Bach","year":"2015","journal-title":"Blood."},{"issue":"5","key":"2021123016465484100_CIT0017","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1111\/j.1538-7836.2007.02477.x","article-title":"Effect of the anti-factor Xa and anti-factor IIa activities of low-molecular-weight heparins upon the phases of thrombin generation","volume":"5","author":"Gerotziafas","year":"2007","journal-title":"J Thromb Haemost."},{"issue":"5","key":"2021123016465484100_CIT0018","doi-asserted-by":"crossref","DOI":"10.3390\/molecules22050713","article-title":"Heparin, heparan sulphate and the TGF-beta cytokine superfamily","volume":"22","author":"Rider","year":"2017","journal-title":"Molecules"},{"issue":"3","key":"2021123016465484100_CIT0019","doi-asserted-by":"crossref","first-page":"892","DOI":"10.2353\/ajpath.2008.080001","article-title":"von-Willebrand factor influences blood brain barrier permeability and brain inflammation in experimental allergic encephalomyelitis","volume":"173","author":"Noubade","year":"2008","journal-title":"Am J Pathol."},{"issue":"9","key":"2021123016465484100_CIT0020","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1161\/ATVBAHA.113.301362","article-title":"Endothelial Von Willebrand factor promotes blood-brain barrier flexibility and provides protection from hypoxia and seizures in mice","volume":"33","author":"Suidan","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol."},{"issue":"15","key":"2021123016465484100_CIT0021","doi-asserted-by":"crossref","first-page":"3600","DOI":"10.1182\/blood-2008-09-180695","article-title":"Deficiency of von Willebrand factor protects mice from ischemic stroke","volume":"113","author":"Kleinschnitz","year":"2009","journal-title":"Blood."},{"issue":"15","key":"2021123016465484100_CIT0022","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.1182\/blood-2009-03-213264","article-title":"von Willebrand factor-cleaving protease ADAMTS13 reduces ischemic brain injury in experimental stroke","volume":"114","author":"Zhao","year":"2009","journal-title":"Blood."},{"issue":"1","key":"2021123016465484100_CIT0023","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1182\/blood-2016-10-747089","article-title":"ADAMTS13 controls vascular remodeling by modifying VWF reactivity during stroke recovery","volume":"130","author":"Xu","year":"2017","journal-title":"Blood."},{"issue":"9","key":"2021123016465484100_CIT0024","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1182\/blood-2015-07-654921","article-title":"A novel role for von Willebrand factor in the pathogenesis of experimental cerebral malaria","volume":"127","author":"O\u2019Regan","year":"2016","journal-title":"Blood."},{"issue":"22","key":"2021123016465484100_CIT0025","doi-asserted-by":"crossref","first-page":"4712","DOI":"10.1182\/blood-2010-03-276311","article-title":"von Willebrand factor promotes leukocyte extravasation","volume":"116","author":"Petri","year":"2010","journal-title":"Blood."},{"issue":"3","key":"2021123016465484100_CIT0026","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1161\/ATVBAHA.117.309918","article-title":"Endothelial cell-derived von Willebrand factor, but not platelet-derived, promotes atherosclerosis in apolipoprotein e-deficient mice","volume":"38","author":"Doddapattar","year":"2018","journal-title":"Arterioscler Thromb Vasc Biol."},{"issue":"14","key":"2021123016465484100_CIT0027","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1182\/blood-2015-03-632901","article-title":"Platelet-derived VWF is not essential for normal thrombosis and hemostasis but fosters ischemic stroke injury in mice","volume":"126","author":"Verhenne","year":"2015","journal-title":"Blood."},{"issue":"12","key":"2021123016465484100_CIT0028","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1182\/blood-2016-12-750711","article-title":"Platelet secretion is crucial to prevent bleeding in the ischemic brain but not in the inflamed skin or lung in mice","volume":"129","author":"Deppermann","year":"2017","journal-title":"Blood."},{"issue":"7","key":"2021123016465484100_CIT0029","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1002\/jnr.22316","article-title":"Endothelial cell heterogeneity of blood-brain barrier gene expression along the cerebral microvasculature","volume":"88","author":"Macdonald","year":"2010","journal-title":"J Neurosci Res."},{"issue":"11","key":"2021123016465484100_CIT0030","doi-asserted-by":"crossref","first-page":"3275","DOI":"10.1161\/STROKEAHA.113.000736","article-title":"Brain regulation of thrombosis and hemostasis: from theory to practice","volume":"44","author":"Fisher","year":"2013","journal-title":"Stroke."},{"issue":"4","key":"2021123016465484100_CIT0031","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.thromres.2013.01.015","article-title":"von Willebrand factor and cancer: a renewed interest","volume":"131","author":"Franchini","year":"2013","journal-title":"Thromb Res."},{"issue":"1-2","key":"2021123016465484100_CIT0032","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.thromres.2003.08.018","article-title":"ADAMTS-13 activity in patients with brain and prostate tumors is mildly reduced, but not correlated to stage of malignancy and metastasis","volume":"111","author":"B\u00f6hm","year":"2003","journal-title":"Thromb Res."},{"issue":"9","key":"2021123016465484100_CIT0033","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1182\/blood.V98.9.2730","article-title":"Changes in health and disease of the metalloprotease that cleaves von Willebrand factor","volume":"98","author":"Mannucci","year":"2001","journal-title":"Blood."},{"issue":"12","key":"2021123016465484100_CIT0034","doi-asserted-by":"crossref","first-page":"4033","DOI":"10.1182\/blood-2002-05-1401","article-title":"ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions","volume":"100","author":"Dong","year":"2002","journal-title":"Blood."},{"issue":"4","key":"2021123016465484100_CIT0035","doi-asserted-by":"crossref","first-page":"e10208","DOI":"10.1371\/journal.pone.0010208","article-title":"Predictive features of severe acquired ADAMTS13 deficiency in idiopathic thrombotic microangiopathies: the French TMA reference center experience","volume":"5","author":"Coppo","year":"2010","journal-title":"PLoS One."},{"issue":"25","key":"2021123016465484100_CIT0036","doi-asserted-by":"crossref","first-page":"4107","DOI":"10.1182\/blood-2013-04-496851","article-title":"Altered glycosylation of platelet-derived von Willebrand factor confers resistance to ADAMTS13 proteolysis","volume":"122","author":"McGrath","year":"2013","journal-title":"Blood."},{"issue":"5","key":"2021123016465484100_CIT0037","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1182\/blood.V60.5.1132.1132","article-title":"Multimeric structure of platelet factor VIII\/von Willebrand factor: the presence of larger multimers and their reassociation with thrombin-stimulated platelets","volume":"60","author":"Fernandez","year":"1982","journal-title":"Blood."},{"issue":"8","key":"2021123016465484100_CIT0038","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1111\/j.1538-7836.2012.04797.x","article-title":"Contribution of platelet vs. endothelial VWF to platelet adhesion and hemostasis","volume":"10","author":"Kanaji","year":"2012","journal-title":"J Thromb Haemost."},{"issue":"19","key":"2021123016465484100_CIT0039","doi-asserted-by":"crossref","first-page":"3990","DOI":"10.1182\/blood-2010-02-269266","article-title":"von Willebrand factor self-association on platelet GpIbalpha under hydrodynamic shear: effect on shear-induced platelet activation","volume":"116","author":"Dayananda","year":"2010","journal-title":"Blood."},{"issue":"7","key":"2021123016465484100_CIT0040","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1038\/bjc.1997.486","article-title":"Enhanced expression of vascular endothelial growth factor in metastatic melanoma","volume":"76","author":"Salven","year":"1997","journal-title":"Br J Cancer."},{"issue":"6","key":"2021123016465484100_CIT0041","first-page":"4255","article-title":"Prognostic value of serum VEGF in melanoma patients: a pilot study","volume":"24","author":"Ascierto","year":"2004","journal-title":"Anticancer Res."},{"issue":"12","key":"2021123016465484100_CIT0042","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1093\/annonc\/mdz237","article-title":"Adjuvant bevacizumab for melanoma patients at high risk of recurrence: survival analysis of the AVAST-M trial","volume":"30","author":"Corrie","year":"2019","journal-title":"Ann Oncol."},{"issue":"2","key":"2021123016465484100_CIT0043","first-page":"341","article-title":"Vascular endothelial growth factor-A(165) induces progression of melanoma brain metastases without induction of sprouting angiogenesis","volume":"62","author":"K\u00fcsters","year":"2002","journal-title":"Cancer Res."},{"issue":"17","key":"2021123016465484100_CIT0044","first-page":"4959","article-title":"Expression of vascular endothelial growth factor is necessary but not sufficient for production and growth of brain metastasis","volume":"60","author":"Yano","year":"2000","journal-title":"Cancer Res."},{"issue":"39","key":"2021123016465484100_CIT0045","doi-asserted-by":"crossref","first-page":"5808","DOI":"10.1038\/sj.onc.1210360","article-title":"Micronodular transformation as a novel mechanism of VEGF-A-induced metastasis","volume":"26","author":"K\u00fcsters","year":"2007","journal-title":"Oncogene."},{"issue":"2","key":"2021123016465484100_CIT0046","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1083\/jcb.200408130","article-title":"Endothelial barrier disruption by VEGF-mediated Src activity potentiates tumor cell extravasation and metastasis","volume":"167","author":"Weis","year":"2004","journal-title":"J Cell Biol."},{"issue":"22","key":"2021123016465484100_CIT0047","doi-asserted-by":"crossref","first-page":"6570","DOI":"10.1158\/1078-0432.CCR-18-1624","article-title":"The evolving modern management of brain metastasis","volume":"25","author":"Fecci","year":"2019","journal-title":"Clin Cancer Res."},{"issue":"3","key":"2021123016465484100_CIT0048","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ccell.2017.07.001","article-title":"Intravascular survival and extravasation of tumor cells","volume":"32","author":"Strilic","year":"2017","journal-title":"Cancer Cell."},{"issue":"9","key":"2021123016465484100_CIT0049","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.3390\/ijms17091468","article-title":"Melanoma brain metastasis: mechanisms, models, and medicine","volume":"17","author":"Kircher","year":"2016","journal-title":"Int J Mol Sci"},{"issue":"suppl 2","key":"2021123016465484100_CIT0050","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1016\/S0049-3848(10)70017-7","article-title":"Antimetastatic activities of heparins and modified heparins. Experimental evidence","volume":"125","author":"Borsig","year":"2010","journal-title":"Thromb Res."},{"issue":"10","key":"2021123016465484100_CIT0051","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1200\/JCO.2005.03.134","article-title":"The effect of low molecular weight heparin on survival in patients with advanced malignancy","volume":"23","author":"Klerk","year":"2005","journal-title":"J Clin Oncol."},{"issue":"10","key":"2021123016465484100_CIT0052","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1200\/JCO.2004.10.002","article-title":"Low molecular weight heparin, therapy with dalteparin, and survival in advanced cancer: the Fragmin Advanced Malignancy Outcome Study (FAMOUS)","volume":"22","author":"Kakkar","year":"2004","journal-title":"J Clin Oncol."},{"issue":"5","key":"2021123016465484100_CIT0053","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1200\/JCO.2015.64.0268","article-title":"Randomized phase III trial of standard therapy plus low molecular weight heparin in patients with lung cancer: FRAGMATIC Trial","volume":"34","author":"Macbeth","year":"2016","journal-title":"J Clin Oncol."},{"issue":"19 Pt 1","key":"2021123016465484100_CIT0054","doi-asserted-by":"crossref","first-page":"7003","DOI":"10.1158\/1078-0432.CCR-05-1131","article-title":"Differential metastasis inhibition by clinically relevant levels of heparins\u2013correlation with selectin inhibition, not antithrombotic activity","volume":"11","author":"Stevenson","year":"2005","journal-title":"Clin Cancer Res."},{"issue":"12","key":"2021123016465484100_CIT0055","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1111\/j.1600-0463.2010.02635.x","article-title":"Dalteparin, a low-molecular-weight heparin, promotes angiogenesis mediated by heparin-binding VEGF-A in vivo","volume":"118","author":"Norrby","year":"2010","journal-title":"APMIS."},{"issue":"8","key":"2021123016465484100_CIT0056","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1097\/MBC.0b013e328349f1a8","article-title":"The use of extended perioperative low molecular weight heparin (tinzaparin) to improve disease-free survival following surgical resection of colon cancer: a pilot randomized controlled trial","volume":"22","author":"Auer","year":"2011","journal-title":"Blood Coagul. Fibrinolysis"}],"container-title":["Neuro-Oncology Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/noa\/article-pdf\/3\/1\/vdab175\/41987378\/vdab175.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/noa\/article-pdf\/3\/1\/vdab175\/41987378\/vdab175.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T00:49:45Z","timestamp":1700009385000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/noa\/article\/doi\/10.1093\/noajnl\/vdab175\/6433069"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,1]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1,1]]}},"URL":"https:\/\/doi.org\/10.1093\/noajnl\/vdab175","relation":{},"ISSN":["2632-2498"],"issn-type":[{"value":"2632-2498","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,1,1]]},"published":{"date-parts":[[2021,1,1]]},"article-number":"vdab175"}}